Compare MRBK & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRBK | STXS |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.9M | 183.7M |
| IPO Year | 2018 | 2004 |
| Metric | MRBK | STXS |
|---|---|---|
| Price | $19.96 | $1.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $20.75 | $4.00 |
| AVG Volume (30 Days) | 104.5K | ★ 378.3K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | ★ 30.34 | 16.67 |
| EPS | ★ 0.17 | N/A |
| Revenue | $6,316,000.00 | ★ $29,346,617.00 |
| Revenue This Year | $25.40 | $28.22 |
| Revenue Next Year | $8.15 | $30.47 |
| P/E Ratio | $117.94 | ★ N/A |
| Revenue Growth | ★ 10.13 | N/A |
| 52 Week Low | $12.56 | $1.60 |
| 52 Week High | $21.59 | $3.59 |
| Indicator | MRBK | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 66.66 | 39.14 |
| Support Level | $18.32 | N/A |
| Resistance Level | $20.74 | $1.99 |
| Average True Range (ATR) | 0.58 | 0.10 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 74.73 | 20.51 |
Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.